| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2006 | US20060211748 Sulphydryl compounds in combination with sulpha compounds |
| 09/21/2006 | US20060211747 Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this method |
| 09/21/2006 | US20060211746 Desferrithiocin derivatives and methods of use thereof |
| 09/21/2006 | US20060211745 Methods and compositions for treating cancer |
| 09/21/2006 | US20060211744 3-Pyridinecarboxamide reduces nerve degeneration |
| 09/21/2006 | US20060211743 3-Pyridinecarboxamide reduces nerve degeneration |
| 09/21/2006 | US20060211742 having a purity of at least 95% pure, preferably at least about 97% pure, more preferably at least at least about 99.5% pure; providing rapid relief from hypertension |
| 09/21/2006 | US20060211741 2-Methyl-N-((1R)-1-{6-methyl-5-[(methylsulfonyl)amino]pyridin-2-yl}ethyl)-2-[4-(2,2,2-trifluoro-1, 1-dimethylethyl)phenyl]cyclopropanecarboxamide; analgesics; bioavailability; less drug-drug interaction; solubility; nervous system disorders; headaches; carpal tunnel syndrome; antiinflamatory agents |
| 09/21/2006 | US20060211740 Novel compounds |
| 09/21/2006 | US20060211739 Use of selective P2X7 receptor antagonists |
| 09/21/2006 | US20060211738 Certain substituted diphenyl ureas, as modulators of kinase activity |
| 09/21/2006 | US20060211737 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 09/21/2006 | US20060211736 Glutarimide-containing polyketide analogs and methods thereof |
| 09/21/2006 | US20060211735 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 09/21/2006 | US20060211734 (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists |
| 09/21/2006 | US20060211733 Methods of preventing and treating opioid bowel dysfunction |
| 09/21/2006 | US20060211732 Hydroxamic acid derivatives as antibacterials |
| 09/21/2006 | US20060211731 New substituted pyridine or piperidine compounds |
| 09/21/2006 | US20060211730 Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase |
| 09/21/2006 | US20060211729 Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211727 Novel compounds |
| 09/21/2006 | US20060211726 Ascomycin derivatives for combination treatment with tazorotene |
| 09/21/2006 | US20060211725 Use |
| 09/21/2006 | US20060211724 Hiv integrase inhibitors |
| 09/21/2006 | US20060211723 Aporphine and oxoaporphine compounds and pharmaceutical use thereof |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | US20060211721 Nutraceutical formulation of a cognitive enhancement system |
| 09/21/2006 | US20060211720 Heterocyclic compounds as inhibitors of factor VIIa |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211718 Deazaflavin compounds and methods of use thereof |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211716 (3,4-Dihydro-quinazolin-2-yl)-aryl-amines |
| 09/21/2006 | US20060211715 Quinazoline protein tyrosine phosphatase inhibitors |
| 09/21/2006 | US20060211714 Quinazoline derivatives and their use in the treatment of cancer |
| 09/21/2006 | US20060211713 Compounds having selective hydrolytic potentials |
| 09/21/2006 | US20060211712 E.g., 6'-Chloro-3-methyl-5'-{[2-(2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetyl]amino}-spiro[imidazolidine-4,2'-indane]-2,5-dione; treating migraines and cluster headaches optionally with serotonin agonists, analgesics, anti-inflammatory agents, anti-hypertensives and/or anticonvulsants. |
| 09/21/2006 | US20060211711 7-(Alkinylamino)-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds |
| 09/21/2006 | US20060211710 Substituted aryl 1,4-pyrazine derivatives |
| 09/21/2006 | US20060211709 Protein kinase modulators and methods of use |
| 09/21/2006 | US20060211708 Ziprasidone free from colored impurities and a process for its preparation |
| 09/21/2006 | US20060211707 Piperazine-alkyl-ureido derivatives |
| 09/21/2006 | US20060211706 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents |
| 09/21/2006 | US20060211705 a protein tyrosine kinase inhibitor; useful in the treatment of immunologic and oncological diseases; 2-(6-chloro-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-(hydroxymethyl)phenyl)thiazole-5-carboxamide |
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211703 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions |
| 09/21/2006 | US20060211702 protein kinase inhibitors used for the treatment of cancers and/or prophylaxis of disorders associated with neurodegeneration resulting from ischemia, cardiac arrest, stroke and multi-infarct dementia |
| 09/21/2006 | US20060211701 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 09/21/2006 | US20060211700 (R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma |
| 09/21/2006 | US20060211699 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/21/2006 | US20060211698 Bicyclic heteroaryl derivatives for treating viruses |
| 09/21/2006 | US20060211697 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211695 Fused heterocyclic kinase inhibitors |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211693 Cis-imidazolines |
| 09/21/2006 | US20060211692 reacting cis-hydroxy-D-proline with 4-chlorophenyl iso-cyanate forming intermediate 1(4-chlorophenylcarbamoyl)-4-hydroxypyrrolidine-2-carboxylic acid, reacting intermediate with aminophenylmorpholinone; 1-[(4-chlorophenyl)]-2-{[4-(3-oxomorpholin-4-yl)phenyl]}-(2R)-pyrrolidine-1,2-dicarboxamide |
| 09/21/2006 | US20060211691 Use of 2h-[1,3]-oxazino[3,2-a] indole derivatives for the treatment of neuropathic pain |
| 09/21/2006 | US20060211690 Microglia inhibitors for interrupting interleukin 12 and IFNgamma-mediated immune reactions |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211688 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/21/2006 | US20060211687 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | US20060211686 Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions |
| 09/21/2006 | US20060211685 Pharmaceutical compositions for the treatment and/or prevention of depression |
| 09/21/2006 | US20060211684 Use of alpha-2 adrenergic receptor agonists |
| 09/21/2006 | US20060211683 Erastin and erastin binding proteins, and uses thereof |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211681 Adenosine deaminase inhibitor and novel bacillus sp. iada-7 strain which produces it |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211679 Substituted lactams as inhibitors of Abeta protein production |
| 09/21/2006 | US20060211678 e.g. 4-[4-(4-Fluoro-3-thiazol-5-ylphenylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; tyrosine and serine/threonine kinase inhibitor; anticarcinogenic agent |
| 09/21/2006 | US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents |
| 09/21/2006 | US20060211676 trihemihydrate crystal form of 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide]-3-vinyl-3-cephem-4-carboxylic acid (cefdinir); powder diffraction pattern having 2 theta values of about 5.9 degrees , 8.1 degrees , 11.8 degrees , 15.7 degrees , 16.2 degrees , 22.6 degrees and 23.1 degrees; bactericide |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211674 Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor |
| 09/21/2006 | US20060211673 Modulation of neurodegenerative diseases through the estrogen receptor |
| 09/21/2006 | US20060211672 Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis |
| 09/21/2006 | US20060211671 agonists used for prevention of obesity in mammals; receptor binding assay; drug screening |
| 09/21/2006 | US20060211670 Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates |
| 09/21/2006 | US20060211669 Synthesis of estetrol via estrone derived steroids |
| 09/21/2006 | US20060211668 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 09/21/2006 | US20060211667 Use of pregnane steroid derivatives for enhancing physical performance |
| 09/21/2006 | US20060211666 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| 09/21/2006 | US20060211665 Reduction of postoperative pain medication |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211663 Low dose estrogen interrupted hormone replacement therapy |
| 09/21/2006 | US20060211662 Combination therapy for topical application in the treatment of age-related macular degeneration and ocular hypertension |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211660 Combination therapy for topical application in the treatment of dry eye syndrome |
| 09/21/2006 | US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 09/21/2006 | US20060211658 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 09/21/2006 | US20060211657 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 09/21/2006 | US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211652 Method of making a partially hydrolyzed fucoidan composition |
| 09/21/2006 | US20060211651 Persulfated oligosaccharide acting on selectins and chemokine |
| 09/21/2006 | US20060211650 Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof |
| 09/21/2006 | US20060211649 Use of cytisine for enhancing physical performance |
| 09/21/2006 | US20060211648 Naphthalimide compositions and uses thereof |
| 09/21/2006 | US20060211646 Formulations with anti-tumour action |